A rating scale for depression.

Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA (2010) 13.88

Cognitive behaviour therapy-based intervention by community health workers for mothers with depression and their infants in rural Pakistan: a cluster-randomised controlled trial. Lancet (2008) 7.69

Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ (1993) 7.14

The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review. J Consult Clin Psychol (2010) 6.81

Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci U S A (2003) 6.46

Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA (2008) 5.96

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology (2009) 5.94

Facilitated physical activity as a treatment for depressed adults: randomised controlled trial. BMJ (2012) 5.61

Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A (1996) 5.24

Edinburgh primary care depression study: treatment outcome, patient satisfaction, and cost after 16 weeks. BMJ (1992) 4.99

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry (2010) 4.85

Detecting anxiety and depression in general medical settings. BMJ (1988) 4.79

Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry (2006) 4.74

Influence of leisure activity on the incidence of Alzheimer's disease. Neurology (2001) 4.49

Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch Gen Psychiatry (2006) 4.30

Toward a neuroimaging treatment selection biomarker for major depressive disorder. JAMA Psychiatry (2013) 4.12

The default mode network and self-referential processes in depression. Proc Natl Acad Sci U S A (2009) 4.05

Prevalence of Depression and Depressive Symptoms Among Resident Physicians: A Systematic Review and Meta-analysis. JAMA (2015) 4.04

Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am J Psychiatry (2009) 3.96

Development of a computerized adaptive test for depression. Arch Gen Psychiatry (2012) 3.77

Efficacy of brief behavioral treatment for chronic insomnia in older adults. Arch Intern Med (2011) 3.73

Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. Br J Psychiatry (2010) 3.72

Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology (2006) 3.72

Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry (2008) 3.64

Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev (2010) 3.46

Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs. Addiction (2011) 3.42

Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci U S A (2003) 3.29

Role of pill-taking, expectation and therapeutic alliance in the placebo response in clinical trials for major depression. Br J Psychiatry (2014) 3.28

A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol (2009) 3.26

Chronic and treatment resistant depression: diagnosis and stepwise therapy. Dtsch Arztebl Int (2014) 3.14

Default-mode and task-positive network activity in major depressive disorder: implications for adaptive and maladaptive rumination. Biol Psychiatry (2011) 3.09

The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease. Am J Psychiatry (2013) 3.06

Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiatry (2002) 3.05

Early intervention for psychosis. Cochrane Database Syst Rev (2011) 3.04

An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report. Biol Psychiatry (2005) 3.03

Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task. J Psychiatr Res (2008) 3.01

Attention modification program in individuals with generalized anxiety disorder. J Abnorm Psychol (2009) 2.99

Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry (2010) 2.98

Treatment of depressive disorders. Dtsch Arztebl Int (2008) 2.96

Effect of telephone-administered vs face-to-face cognitive behavioral therapy on adherence to therapy and depression outcomes among primary care patients: a randomized trial. JAMA (2012) 2.95

Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry (2006) 2.93

Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry (2008) 2.86

The effect of a primary care practice-based depression intervention on mortality in older adults: a randomized trial. Ann Intern Med (2007) 2.84

Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial. Subst Abus (2009) 2.83

Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry (2015) 2.76

Attention training in individuals with generalized social phobia: A randomized controlled trial. J Consult Clin Psychol (2009) 2.76

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry (2012) 2.74

Validation of hippocampal volumes measured using a manual method and two automated methods (FreeSurfer and IBASPM) in chronic major depressive disorder. Neuroradiology (2008) 2.73

Comparison of St John's wort and imipramine for treating depression: randomised controlled trial. BMJ (2000) 2.71

Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics. Psychopharmacology (Berl) (2004) 2.69

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry (2013) 2.68

Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review. Psychol Bull (2012) 2.65

Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. BMJ (1992) 2.64

Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord (2007) 2.62

Altered emotional interference processing in affective and cognitive-control brain circuitry in major depression. Biol Psychiatry (2007) 2.61

Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial. JAMA (2009) 2.60

Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-Child study. Am J Psychiatry (2011) 2.58

Anticipatory activation in the amygdala and anterior cingulate in generalized anxiety disorder and prediction of treatment response. Am J Psychiatry (2009) 2.57

Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull (2007) 2.56

Reducing suicidal ideation and depression in older primary care patients: 24-month outcomes of the PROSPECT study. Am J Psychiatry (2009) 2.56

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet (2006) 2.55

Risk for recurrence in depression. Clin Psychol Rev (2007) 2.52

Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial. JAMA Psychiatry (2013) 2.49

Mindfulness-based cognitive therapy for preventing relapse in recurrent depression: a randomized dismantling trial. J Consult Clin Psychol (2013) 2.46

Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial. Lancet (2015) 2.42

Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A (2004) 2.41

Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry (2002) 2.41

Therapist adherence/competence and treatment outcome: A meta-analytic review. J Consult Clin Psychol (2010) 2.41

From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull (2014) 2.39

A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. Am J Psychiatry (2008) 2.34

A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. Am J Psychiatry (2010) 2.34

Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA Psychiatry (2014) 2.33

Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Mol Psychiatry (2011) 2.32

Molecular signatures of major depression. Curr Biol (2015) 2.28

Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry (2007) 2.27

Mediation analysis with principal stratification. Stat Med (2009) 2.27

Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease. Am J Geriatr Psychiatry (2006) 2.26

Brief interpersonal psychotherapy for depressed mothers whose children are receiving psychiatric treatment. Am J Psychiatry (2008) 2.25

Diabetes, depression, and death: a randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT). Diabetes Care (2007) 2.23

Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects. J Consult Clin Psychol (2007) 2.22

Psychosis with good prognosis in Afro-Caribbean people now living in the United Kingdom. BMJ (1995) 2.22

Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci U S A (2000) 2.19

Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients. Eur Arch Psychiatry Clin Neurosci (2014) 2.18

Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study. Neuropsychopharmacology (2012) 2.17

A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Arch Gen Psychiatry (2009) 2.15

Decreased volume of the brain reward system in alcoholism. Biol Psychiatry (2008) 2.15

Reduced capacity to sustain positive emotion in major depression reflects diminished maintenance of fronto-striatal brain activation. Proc Natl Acad Sci U S A (2009) 2.15

Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Efficacy Results From a Randomized, Double-Blind, Placebo-Controlled Study. Am J Psychiatry (2015) 2.14

Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. Psychosomatics (2005) 2.13

Origin of chronic right upper quadrant pain. Gut (1985) 2.11

Prognostic subgroups for citalopram response in the STAR*D trial. J Clin Psychiatry (2014) 2.10

A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder. J Clin Psychiatry (2014) 2.10

Responsiveness to Threat and Incentive in Bipolar Disorder: Relations of the BIS/BAS Scales With Symptoms. J Psychopathol Behav Assess (2001) 2.08

Outcome over seven years of healthy adults with and without subjective cognitive impairment. Alzheimers Dement (2010) 2.07

Cognitive remediation improves memory and psychosocial functioning in first-episode psychiatric out-patients. Psychol Med (2012) 2.07

Remission in depressed geriatric primary care patients: a report from the PROSPECT study. Am J Psychiatry (2005) 2.04

Defining critical white matter pathways mediating successful subcallosal cingulate deep brain stimulation for treatment-resistant depression. Biol Psychiatry (2014) 2.02

Validating a shortened depression scale (10 item CES-D) among HIV-positive people in British Columbia, Canada. PLoS One (2012) 2.02

Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study. Eur J Nucl Med Mol Imaging (2012) 2.01

Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction: effect on disability. Arch Gen Psychiatry (2011) 2.00

The assessment of anxiety states by rating. Br J Med Psychol (1959) 24.58

THE ROLE OF BLOOD-PRESSURE CONTROL IN PREVENTING COMPLICATIONS OF HYPERTENSION. Lancet (1964) 7.09

The aetiology of essential hypertension. 4. The role of inheritance. Clin Sci (Lond) (1954) 4.81

The aetiology of essential hypertension. I. The arterial pressure in the general population. Clin Sci (Lond) (1954) 4.36

The aetiology of essential hypertension. II. Scores for arterial blood pressures adjusted for differences in age and sex. Clin Sci (Lond) (1954) 3.59

Treatment of severe hypertension with methyldopa. Br Med J (1963) 2.29

Arterial pressures of relatives of patients with secondary and malignant hypertension. Clin Sci (1963) 1.53

Measurement in medicine. Lancet (1958) 1.40

The treatment of hypertensive heart failure and of hypertensive cardiac overload by blood pressure reduction. Am J Cardiol (1958) 1.31

Pulmonary-embolic disease. Lancet (1962) 1.30

Unusual manifestations of pulmonary embolic disease. Postgrad Med J (1963) 1.30

Use of succinylcholine in E.C.T., with particular reference to its effect on blood pressure. Br Med J (1953) 1.19

Factors related to the outcome of depression treated with E.C.T. J Ment Sci (1960) 1.17

The treatment of intermittent claudication with vitamin E. Lancet (1953) 1.17

Neurosis in fifty married couples assessed from general practice records, interviews by a psychiatric social worker and the use of the Cornell Medical Index. J Ment Sci (1962) 1.16

The ear oximeter; its use clinically and in the determination of cardiac output. Br Heart J (1954) 1.15

Clinical syndromes in depressive states. J Ment Sci (1959) 1.13

The treatment of intermittent claudication. Q J Med (1952) 1.13

Benactyzine as an aid in treatment of anxiety states; preliminary report. Br Med J (1957) 1.04

Changes in peripheral circulation and body temperature after hexamethonium bromide. Clin Sci (Lond) (1954) 1.01

A controlled trial of thiopropazate dihydrochloride (dartalan). chlorpromazine and occupational therapy in chronic schizophrenics. J Ment Sci (1960) 0.92

Relation of C.M.I. responses to some social and psychological factors. J Psychosom Res (1963) 0.91

Phaeochromocytoma. Br Heart J (1953) 0.90

Treatment of anxiety states. I. The effects of suggestion on the symptoms of anxiety states. J Ment Sci (1958) 0.86

The personality of dyspeptics; with special reference to gastric and duodenal ulcer. Br J Med Psychol (1951) 0.86

SOCIAL FACTORS AND NEUROSIS IN A WORKING-CLASS POPULATION. Br J Psychiatry (1963) 0.84

MARRIAGE AND NEUROSIS IN A WORKING-CLASS POPULATION. Br J Psychiatry (1963) 0.83

Treatment of anxiety states. II. Clinical trial of benactyzine in anxiety states. J Ment Sci (1958) 0.83

Treatment of anxiety states. III. Components of anxiety and their response to benactyzine. J Ment Sci (1958) 0.82

Circulation in lower limb before and after reconstruction of obstructed main artery. Lancet (1960) 0.81

Nomogram for the Rees-Eysenck Body Index. J Ment Sci (1950) 0.80

Action of ecolid in man. Br Med J (1956) 0.78

Drugs and "moral treatment". Br J Psychiatry (1963) 0.76

Autonomic function and syndromes in depression. Proc R Soc Med (1959) 0.75

Belladonna poisoning. Br Med J (1947) 0.75

A simple diagram for obtaining tetrachloric correlation coefficients. Br J Psychol Gen Sect (1949) 0.75

Discussion on methods of psychosomatic medicine; the "duodenal ulcer personality"-a psychometric approach. Proc R Soc Med (1958) 0.75

On the nature of inhibition in the cerebral cortex. Psychol Rev (1952) 0.75

Statistics: retrodisplacement and fertility. Br Med J (1947) 0.75

Safety in car design. Br Med J (1965) 0.75

DR. JESSE BENNETT--PIONEER PHYSICIAN (1769-1842). W V Med J (1964) 0.75

Occupational therapy in Venezuela. Can J Occup Ther (1955) 0.75

The mode of action of drugs used in the treatment of hypertension. Proc R Soc Med (1962) 0.75

Population survey of casual and near-basal blood pressures: with comments on survey techniques. N Z Med J (1962) 0.75

Quantitative assessment of the mecholyl (Funkenstein) test. Acta Psychiatr Scand (1960) 0.75

Ischaemic episodes in cardiac failure: acute arterial insufficiency with and without structural blockage. Med J Aust (1955) 0.75

Nomogram for the tetrachoric correlation coefficient. Psychometrika (1948) 0.75